Європейський Союз -
естонська -
EMA (European Medicines Agency)
jorveza
dr. falk pharma gmbh - budesonide - söögitoruhaigused - antidiarrheals, soole põletikuvastased / antiinfective ained - jorveza on näidustatud eosinofiilse ösofagiidi (eoe) raviks täiskasvanutel (vanematel kui 18-aastastel).
Естонія -
естонська -
Ravimiamet
hypophysin süstelahus
veyx-pharma gmbh - karbetotsiin - süstelahus - 35mcg 1ml 100ml 1tk; 35mcg 1ml 50ml 1tk; 35mcg 1ml 100ml 12tk; 35mcg 1ml 20ml 1tk
Естонія -
естонська -
Ravimiamet
hypophysin süstelahus
veyx-pharma gmbh - karbetotsiin - süstelahus - 70mcg 1ml 10ml 1tk; 70mcg 1ml 20ml 1tk; 70mcg 1ml 50ml 12tk; 70mcg 1ml 50ml 1tk
Естонія -
естонська -
Ravimiamet
cortico veyxin süstesuspensioon
veyx-pharma gmbh - prednisoloon - süstesuspensioon - 8,95mg 1ml 100ml 6tk
Європейський Союз -
естонська -
EMA (European Medicines Agency)
thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastilised ained - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
Європейський Союз -
естонська -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskulaarne blokaad - kõik muud ravitoimingud - rookurooniumi või vekurooniumi poolt indutseeritud neuromuskulaarse blokaadi pöördumine. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Естонія -
естонська -
Ravimiamet
veyxyl tabs intrauteriintablett
veyx-pharma gmbh - amoksitsilliin - intrauteriintablett - 800mg 20tk; 800mg 10tk
Естонія -
естонська -
Ravimiamet
veyx yl la 20% süstesuspensioon
veyx-pharma gmbh - amoksitsilliin - süstesuspensioon - 200mg 1ml 100ml 12tk; 200mg 1ml 100ml 1tk
Естонія -
естонська -
Ravimiamet
spasmalgan compositum süstelahus
veyx pharma gmbh - hüostsiinbutüülbromiid+naatriummetamisool - süstelahus - 4mg+500mg 1ml 100ml 1tk; 4mg+500mg 1ml 10ml 1tk
Естонія -
естонська -
Ravimiamet
gonavet veyx süstelahus
veyx-pharma gmbh - gonadoreliin - süstelahus - 50mcg 1ml 10ml 1tk; 50mcg 1ml 20ml 1tk; 50mcg 1ml 50ml 1tk